{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:27:47Z","timestamp":1789817267774,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8157040652"],"award-info":[{"award-number":["8157040652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900552"],"award-info":[{"award-number":["81900552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12072-020-10126-x","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:06:42Z","timestamp":1611832002000},"page":"720-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt"],"prefix":"10.1007","volume":"15","author":[{"given":"Jiangqiang","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-5831","authenticated-orcid":false,"given":"Yuzheng","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"10126_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0168-8278(03)00231-9","volume":"39","author":"M Chojkier","year":"2003","unstructured":"Chojkier M. Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids. J HEPATOL. 2003;39:437\u201346.","journal-title":"J HEPATOL"},{"key":"10126_CR2","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jgh.14612","volume":"34","author":"YZ Zhuge","year":"2019","unstructured":"Zhuge YZ, Liu YL, Xie WF, et al. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. J Gastroen Hepatol. 2019;34:634\u201342.","journal-title":"J Gastroen Hepatol"},{"key":"10126_CR3","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.3748\/wjg.v25.i28.3753","volume":"28","author":"XQ Yang","year":"2019","unstructured":"Yang XQ, Ye J, Li X, et al. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome\u2013Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J Gastroenterol. 2019;28:3753\u201363.","journal-title":"World J Gastroenterol"},{"key":"10126_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG, et al. Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology. 1994;19:1171\u201380.","journal-title":"Hepatology"},{"key":"10126_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","volume":"54","author":"G Lin","year":"2010","unstructured":"Lin G, Wang JY, Li N, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol. 2010;54:666\u201373.","journal-title":"J Hepatol"},{"key":"10126_CR6","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.diii.2016.10.003","volume":"97","author":"R Loffroy","year":"2016","unstructured":"Loffroy R. Transjugular intrahepatic portosystemic shunt (TIPS): a major step forward for patients but a growing job for interventional radiologists. Diagn Interv Imag. 2016;97:1069\u201370.","journal-title":"Diagn Interv Imag"},{"key":"10126_CR7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0016-5085(03)00377-9","volume":"124","author":"TD Boyer","year":"2003","unstructured":"Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124:1700\u201310.","journal-title":"Gastroenterology"},{"issue":"9","key":"10126_CR8","first-page":"1627","volume":"33","author":"Cooperative Group for Hepatic and Gall Diseases, Chinese Society of Gastroenterology, Chinese Medical ssociation","year":"2017","unstructured":"Cooperative Group for Hepatic and Gall Diseases, Chinese Society of Gastroenterology, Chinese Medical ssociation. Expert consensus on diagnosis and treatment of quinazoline alkaloids-related sinusoidal obstruction syndrome (2017, Nanjing) [J]. J Clin Hepatol. 2017;33(9):1627\u201337 (in Chinese).","journal-title":"J Clin Hepatol"},{"issue":"9","key":"10126_CR9","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/MEG.0000000000001630","volume":"32","author":"CY Peng","year":"2020","unstructured":"Peng CY, Zhang XF, Zhang F, Liu LG, Shao YL, Zhang W, Xiao JQ, Zhuge YZ, et al. Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome. Eur J Gastroen Hepat. 2020;32(9):1168\u201378.","journal-title":"Eur J Gastroen Hepat."},{"key":"10126_CR10","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/MEG.0000000000001452","volume":"31","author":"XC Yin","year":"2019","unstructured":"Yin XC, Zhang F, Xiao JQ, et al. Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients. Eur J Gastroen Hepat. 2019;31:1264\u20139.","journal-title":"Eur J Gastroen Hepat"},{"key":"10126_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","volume":"379","author":"S Corbacioglu","year":"2012","unstructured":"Corbacioglu S, Cesaro S, Faraci M, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet. 2012;379:1301\u20139.","journal-title":"Lancet"},{"issue":"7","key":"10126_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.bbmt.2018.02.015","volume":"24","author":"A Picod","year":"2018","unstructured":"Picod A, Bonnin A, Battipaglia G, et al. Defibrotide for sinusoidal obstruction syndrome_veno-occlusive disease prophylaxis in high-risk adult patients: a single-center experience study. Biol Blood Marrow Tr. 2018;24(7):1471\u20135.","journal-title":"Biol Blood Marrow Tr."},{"issue":"1","key":"10126_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbmt.2018.07.039","volume":"25","author":"LE Roeker","year":"2019","unstructured":"Roeker LE, Kim HT, Glotzbecker B, et al. Early clinical predictors of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome after myeloablative stem cell transplantation. Biol Blood Marrow Tr. 2019;25(1):137\u201344.","journal-title":"Biol Blood Marrow Tr."},{"key":"10126_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/17474124.2017.1370372","volume":"11","author":"S Corbacioglu","year":"2017","unstructured":"Corbacioglu S, Richardson PG. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation. Expert Rev Gastroent. 2017;11:885\u201398.","journal-title":"Expert Rev Gastroent"},{"key":"10126_CR15","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.3748\/wjg.v13.i29.3918","volume":"29","author":"M Senzolo","year":"2007","unstructured":"Senzolo M, Germani G, Cholongitas E, et al. Veno occlusive disease: update on clinical management. World J Gastroenterol. 2007;29:3918\u201324.","journal-title":"World J Gastroenterol"},{"key":"10126_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/lt.22351","volume":"18","author":"I Campos-Varela","year":"2012","unstructured":"Campos-Varela I, Castells L, Dopazo C, et al. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature. Liver Transplant. 2012;18:201\u20135.","journal-title":"Liver Transplant"},{"key":"10126_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bmt.1702386","volume":"25","author":"D Azoulay","year":"2000","unstructured":"Azoulay D, Castaing D, Lemonine A, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transpl. 2000;25:987\u201392.","journal-title":"Bone Marrow Transpl"},{"key":"10126_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2010.11.006","volume":"43","author":"M Senzolo","year":"2011","unstructured":"Senzolo M, Riggio O, Primignani M. Vascular disorders of the liver: recommendations from the Italian association for the study of the liver (AISF) ad hoc committee. Digest Liver Dis. 2011;43:503\u201314.","journal-title":"Digest Liver Dis"},{"key":"10126_CR19","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/liv.13684","volume":"38","author":"YZ Zhuge","year":"2018","unstructured":"Zhuge YZ, Wang Y, Zhang F, et al. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease. LIVER INT. 2018;38:1867\u201374.","journal-title":"LIVER INT"},{"key":"10126_CR20","first-page":"251","volume":"39","author":"CL Hou","year":"2019","unstructured":"Hou CL, Xu J, Qin HL, et al. Efficacy of transjugular intrahepatic portosystemic shunt in the treatment of 21 patients with Gynura segetum-related hepatic sinusoidal obstruction syndrome. Chinese J Digest. 2019;39:251\u20136.","journal-title":"Chinese J Digest"},{"issue":"7","key":"10126_CR21","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","volume":"25","author":"S Corbacioglu","year":"2019","unstructured":"Corbacioglu S, Jabbour E, Mohty M. Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome. Biol Blood Marrow Tr. 2019;25(7):1271\u201380.","journal-title":"Biol Blood Marrow Tr."},{"key":"10126_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1751-2980.2011.00552.x","volume":"13","author":"H Gao","year":"2013","unstructured":"Gao H, Li N, Wang JY, et al. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Digest Dis. 2013;13:33\u20139.","journal-title":"J Digest Dis"},{"key":"10126_CR23","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.2147\/DDDT.S87858","volume":"9","author":"H Gao","year":"2015","unstructured":"Gao H, Ruan JQ, Chen J, et al. Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome. Drug Des Develop Therapy. 2015;9:4861\u20138.","journal-title":"Drug Des Develop Therapy"},{"key":"10126_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","volume":"53","author":"S Corbacioglu","year":"2018","unstructured":"Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transpl. 2018;53:138\u201345.","journal-title":"Bone Marrow Transpl"},{"key":"10126_CR25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/s41409-019-0492-6","volume":"54","author":"JH Yoon","year":"2019","unstructured":"Yoon JH, Yoo KH, Sung KW, Jung CW, Kim JS, Hahn SM, et al. Validation of treatment outcomes according to revised severity criteria from European society for blood and marrow transplantation (EBMT) for sinusoidal obstruction syndrome\/veno-occlusive disease (SOS\/VOD). Bone Marrow Transpl. 2019;54:1361\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"10126_CR26","unstructured":"Chen YR, Zhang W, Zhang M, Zhang F, Xiao JQ, Yin Q, Zhuge YZ et al. (2020) Prognostic value of the PA-HSOS criteria for severity grading in PA-HSOS patients treated with TIPS. Chinese J Heptol Accepted. (in Chinese). (Not published)"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-020-10126-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T09:06:46Z","timestamp":1626599206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-020-10126-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10126"],"URL":"https:\/\/doi.org\/10.1007\/s12072-020-10126-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was obtained. The study was conducted in accordance with the ethical principles laid down in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}